2012 [cited 2024 Nov 25];8:40815
Common side effects are similar to GLP-1 drugs: nausea, vomiting, diarrhea, and constipation
Novo Nordisk is focused on driving change for people living with obesity and is looking for new and innovative ways to connect more patients with the authentic medicines they are seeking and deserve, like Wegovy
Until then, Klinic connects you to trusted healthcare providers for currently approved treatments like Wegovy and Zepbound, fulfilling your present weight loss needs
UK Medical Guidance and Regulatory Perspective In the UK, NICE guidance for type 2 diabetes (NG28) and obesity management (TA1026) does not specifically address cannabis use in conjunction with GLP-1 receptor agonists like tirzepatide
You shouldnt have to choose between your health and your wallet.